{{Drugbox
| IUPAC_name = 5-Chloro-7-({[3-(diethylamino)propyl]amino}methyl)quinolin-8-ol
| image = Clamoxyquine.svg
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number = 2545-39-3
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 18029
| DrugBank =  
| ChEMBL = 2106065
| ChemSpiderID = 17033
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = JUN13FZ6RF
<!--Chemical data-->
| C=17 | H=24 | Cl=1 | N=3 | O=1
| molecular_weight = 321.846 g·mol<sup>−1</sup>
| smiles = Clc1cc(c(O)c2ncccc12)CNCCCN(CC)CC
}}

'''Clamoxyquine''' ([[International Nonproprietary Name|INN]]) or '''clamoxyquin''' (former [[British Approved Name|BAN]]), as the [[pamoate]] or [[hydrochloride]] salt, is an [[antiparasitic|antiamebic]] and [[antidiarrheal]] drug.

It has been used as a [[veterinary medicine]] to treat [[salmonidae|salmonids]] for infection with the [[myxozoan]] [[parasite]] ''[[Myxobolus cerebralis]]''.
==Synthesis==
Antimalarial activity also predominates in a quinoline that bears a diaminoalkyl side chain at a rather different position from the other agents noted. 
[[File:Clamoxyquin synthesis.svg|thumb|center|500px|Clamoxyquin synthesis:<ref>{{Cite journal | doi = 10.1021/jo01068a103| title = Antiamebic Agents. V.1Promising Basic Amebicides Derived from 5-Chloro-8-quinolinol| journal = The Journal of Organic Chemistry| volume = 26| issue = 10| pages = 4070| year = 1961| last1 = Burckhalter | first1 = J. H.| last2 = Brinigar | first2 = W. S. | last3 = Thompson | first3 = P. E. }}</ref>]]
Thus, Mannich condensation of the hydroxyquinoline ('''1''') with [[formaldehyde]] and N,N-diethylpropylenediamine affords clamoxyquin ('''2''').

==References==
{{Reflist|2}}

[[Category:Veterinary drugs]]
[[Category:Quinolines]]
[[Category:Chloroarenes]]

{{Antiinfective-drug-stub}}
{{Veterinary-med-stub}}